The importance of this protein interaction is freshly reinforced by findings that MPN-associated JAK2 mutants use EPOR as a scaffold for recruiting downstream substrates in order to drive EPO-independent erythrocytosis129. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.